• Breaking News

    Very early marker of cardiac damage triggered by cancer treatment

    Researchers have identified a very early marker of cardiac damage in patients undergoing therapy with anthracyclines, a family of drugs commonly used to treat cancer. This finding will enable the early diagnosis of the cardiotoxicity associated with this group of widely used chemotherapy drugs.

    from Latest Science News -- ScienceDaily http://bit.ly/2DRfLmN

    No comments

    Post Top Ad


    Post Bottom Ad